Predictive and prognostic factors influencing outcomes of rituximab therapy in systemic lupus erythematosus (SLE): A systematic review. [electronic resource]
- Seminars in arthritis and rheumatism 12 2017
- 384-396 p. digital
Antirheumatic Agents--therapeutic use Biomarkers--blood Cohort Studies Female Humans Lupus Erythematosus, Systemic--drug therapy Male Observational Studies as Topic Randomized Controlled Trials as Topic Rituximab--therapeutic use Severity of Illness Index Treatment Outcome